Quick recap
The meeting focused on discussions about kratom regulation, industry challenges, and advocacy efforts. Christopher shared insights from a conversation with an addiction doctor who is interested in learning more about kratom as a leaf versus other products in the market. The group discussed recent news about a theft of $6,740 worth of kratom products, debated the effectiveness of fentanyl test strips, and examined the challenges of proper kratom education being restricted on social media platforms despite allowing other potentially harmful content. They also discussed the need for better regulation of kratom products, particularly addressing concerns about enhanced extracts like 7OH, and explored ways to present fiscal impact data to states considering bans. The conversation touched on personal experiences with medical cannabis and the importance of proper plant medicine usage, while emphasizing the need for proper education and regulation in the kratom industry.
Summary
Wi-Fi Coverage Discussion Meeting
Christopher and Venus discussed Wi-Fi coverage issues at their location. Christopher explained his decision not to expand Wi-Fi to the office area and shared his positive experience with a Wi-Fi extender. They also briefly discussed a news article about a police officer who had stolen something other than Kratom.
Kratom Theft and Enforcement Discussion
Christopher and Venus discussed a recent theft of $6,740 worth of kratom tablets, with Christopher questioning the reported value given typical retail prices. They also discussed the challenges of drug enforcement and addiction treatment, including the limited effectiveness of fentanyl test strips as people often continue using contaminated drugs. Christopher shared a positive conversation with an addiction doctor who is open to learning about kratom as a leaf and other products in the market.
Kratom Regulation and Advocacy Challenges
Christopher and Venus discussed the changing landscape of drugs and chemicals, particularly the increased prevalence and abuse of enhanced Kratom products like 7OH. They highlighted the lack of awareness among consumers about different Kratom products and the challenges in providing education due to social media restrictions. Christopher expressed frustration over politicians' disregard for public opinion and evidence during hearings on Kratom regulation, attributing it to political agendas or ignorance. Venus noted that despite challenges, the advocacy efforts are growing louder.
Kratom and Cannabis Regulation Challenges
Christopher and Venus discussed the challenges and politics surrounding kratom and cannabis regulation. Christopher emphasized the importance of smaller companies focusing on keeping kratom legal rather than getting involved in politics. They also talked about personal experiences with cannabis use, including its medicinal benefits and the risks of illegal possession, particularly in states with strict regulations. Christopher shared his preference for using kratom over other products and expressed frustration with the political landscape affecting access to natural remedies.
Medical Cannabis and Kratom Discussion
Christopher and Venus discussed their experiences with medical cannabis and kratom. Christopher shared his perspective on using cannabis for medical purposes and the benefits of having a medical card for legal protection. They talked about different types of cannabis strains, with Christopher preferring indica over sativa. The conversation also covered the science behind cannabis and kratom, including the concept of the entourage effect and traditional methods of consumption like brewing kratom as a decoction. Christopher mentioned his interest in plant medicine and shared a story about accidentally making kratom kombucha.
Aging Care and Advocacy Updates
Christopher shared personal experiences about caring for his aging dog with dementia, drawing parallels to his mother's experience with the condition. He discussed setting up a podcast room to focus on advocacy work and mentioned attending the National Conference of State Legislators in Denver where he met with Arkansas legislators to discuss Kratom legislation. The conversation ended with Venus mentioning an upcoming case in Arkansas involving Speaker Marshall, which Christopher expressed concern about wanting to follow and potentially provide input on.
Criminal Case and Fiscal Impact
The group discussed the criminal case involving a patient who died after receiving inadequate medical care, with Christopher and Venus expressing their outrage at the nurses' inaction. Robin raised concerns about states not accounting for the financial impact of banning certain activities, noting the absence of fiscal impact statements that were previously common. Christopher mentioned his work on developing an AI tool to analyze the fiscal impact of such bans across different states.
Kratom Regulation Financial Impact Analysis
Christopher discussed his work on developing a comprehensive financial impact analysis tool for kratom regulations, which goes beyond traditional fiscal notes to include costs like incarceration, medical care, and lost wages. He shared his experience with registration costs in different states, noting that Utah's new regulations effectively ban most kratom products except powder sold at licensed tobacco retailers. The group discussed the importance of letter of intent filings as a strategic approach to challenge regulations, with Robin suggesting that multiple companies joining such efforts could be more effective than individual lawsuits.
Kratom and Recovery Discussion
Christopher shared his personal experiences with knee pain and recent vascular surgeries, including challenges with pain management using Kratom. He discussed his recovery process and plans to start walking as the weather improves. Christopher also explained his conversation with Dr. Watson, a recovery specialist from Pennsylvania, about the current issues with Kratom products, particularly the standalone 70H products, and emphasized the importance of understanding the differences between various Kratom products.
Kratom Regulation and Safety Issues
Christopher discussed the issues with unregulated kratom products, particularly those containing unknown chemicals like pseudoendoxyl and 7-OH. He met with a sincere individual who is not seeking to ban kratom but wants to address the problem of unregulated products that can harm consumers. Christopher emphasized the need to remove problematic commercial products from the market and then re-evaluate regulated versions, though he acknowledged that government processes would likely be slow.
Kratom Product Safety Concerns
Christopher and Robin discussed the challenges and concerns surrounding kratom products, particularly the lack of scientific research on 70H and the rise of potentially addictive extracts. Christopher emphasized his support for natural leaf kratom and expressed concerns about the industry's direction, including the use of high-dose extracts and aggressive marketing tactics. They also discussed the difficulties in educating the public about kratom due to censorship on social media platforms, highlighting the need for better regulation and more accurate information about the product.